Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|October 25, 2007
Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activityMark L Hartman, Arthur Weltman, Anthony Zagar, et al.Neurobiology of Aging|January 10, 2006
Growth hormone releasing hormone improves the cognition of healthy older adultsMichael V Vitiello, Karen E Moe, George R Merriam, et al.Archives of Neurology|August 8, 2012
Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trialLaura D Baker, Suzanne M Barsness, Soo Borson, et al.The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice GuidelineMark E Molitch, David R Clemmons, Saul Malozowski, et al.The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Elevation in serum thyroglobulin during prolonged Antarctic residence: effect of thyroxine supplement in the polar 3,5,3'-triiodothyronine syndromeNhan Van Do, Lizbeth Mino, George R Merriam, et al.Journal of Alzheimer'S Disease : JAD|July 24, 2009
Effects of insulin and octreotide on memory and growth hormone in Alzheimer's diseaseG Stennis Watson, Laura D Baker, Brenna A Cholerton, et al.Menopause (New York, N.Y.)|April 12, 2006
Postmenopausal hormone therapy: new questions and the case for new clinical trialsJoann E Manson, Shari S Bassuk, S Mitchell Harman, et al.JAMA Neurology|May 22, 2013
Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy agingSeth D Friedman, Laura D Baker, Soo Borson, et al.The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Effects of an oral growth hormone secretagogue in older adultsHeidi K White, Charles D Petrie, William Landschulz, et al.The Journal of Clinical Endocrinology and Metabolism|April 16, 2013
A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsKevin C J Yuen, Gerard S Conway, Vera Popovic, et al.Pageof 3